US suit by pension plan on ImClone buyout hits snag - update
This article was originally published in Scrip
Executive Summary
Lilly's proposed $6.5 billion all-cash offer for ImClone Systemsis being challenged in a New York court, according to a regulatory filing by ImClone. It remains unclear, however, how much of a potential roadblock the suit will be.